脑部放疗，上午比下午敏感许多！' S! c5 U' v2 |+ Z
% s% r: E: o2 B9 e) ^ R4 d
. I) E" C" M% U. }# T' q: f( u. OCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.( q9 n8 z# z/ E- a l' s5 P
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
, l6 b, c+ `0 t4 K1 e hRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.. k, t3 O4 ?6 A
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
: U5 P+ ^ M" N: v6 Y
/ ?5 V4 m8 G/ F3 r8 R2 @Abstract. f4 p9 |( i3 x b! }
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.' A: ^9 N, h6 v/ h1 a( x/ ~
! c; q, z8 j, c; E5 A7 |: L. k
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.1 z$ s8 p1 h' K) q8 c+ t! u' V) {( t
' S+ ^5 @6 {& ^* c* h HRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
2 f2 B+ f. `3 \& D: D# c, v. j) K
7 N7 O5 m9 T$ y k4 ^+ C. ACONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
6 T$ o( q' H# o0 p# t, m C$ h9 S5 Z ]: a7 k
|
汇总4月最新：临床试验招募| 小细胞
"化疗±免疫后进展了，还能怎么办？"——这是许多小细胞肺癌患者和家属的困境。
临
新人求助
我爸爸身体不适 26 年 4 月 10 号去医院检查，初步结果是肺肿可能是肺癌，因年纪大 7
母亲肺腺癌晚期骨转移，EGFR21突变，
母亲1970年出生，56周岁，身高163cm，体重98kg（196斤）。2025年9月23日肺炎住院，胸
肺癌术后五年，脑膜转移治疗三年，伏
2025年8月14日更新: 终于输液港血培养结果为阴性了，14天美平消炎出院了，昨天开始双
从6个月到1400多天：一位晚期肺癌患
2026年全国肿瘤防治宣传周（4月15日-21日）即将到来，今年中国抗癌协会的主题是“肿瘤
11011102001537 )
4 q, i/ X0 G9 s9 F
显身卡
